tradingkey.logo

SpringWorks Therapeutics rises after Germany's Merck KGaA to buy co in $3.9 bln deal

ReutersApr 28, 2025 11:46 AM

Shares of biotech firm SpringWorks Therapeutics SWTX.O rise 3.2% to $46.13 premarket

Germany's Merck KGaA MRCG.DE has struck a deal to buy co for an equity value of $3.9 billion

Offer price of $47 per share is a premium of 5.1% to last close

But price 22% lower than the about $60 per share analysts expected after a Reuters report on February 10 that the companies were in advanced talks

Transaction will likely close during the second half of 2025, Merck says

Up to last close, SWTX up 23.8% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI